Vox Markets Logo

PMH Capital

IXICO secures £1.3m in new global neuroimaging contracts

IXICO secures £1.3m in new global neuroimaging contracts

3 days ago

IXICO has secured two new contracts worth c. £1.3 million to provide advanced neuroimaging services for clinical trials in Alzheimer's Disease and Friedreich's Ataxia.

Venture Life completes strategic divestment, reports strong H1 growth

Venture Life completes strategic divestment, reports strong H1 growth

22 days ago

Venture Life has completed the sale of its CDMO business, reported 38% H1 revenue growth, and announced key senior appointments to support its brand-led growth strategy.

Eleco posts record recurring revenues, strong cash generation in H1

Eleco posts record recurring revenues, strong cash generation in H1

23 days ago

Eleco reported a strong H1 2025, delivering record ARR growth of 19%, total revenue growth of 13%, and maintaining a solid cash position despite acquisition-related costs.

IXICO signs data access deal with GAP to bolster Alzheimer's research

IXICO signs data access deal with GAP to bolster Alzheimer's research

24 days ago

IXICO has signed a strategic agreement with the Global Alzheimer's Platform Foundation to gain full data rights to the Bio-Hermes-002 study, enhancing its AI-driven biomarker capabilities in Alzheimer's research.

IXICO Revenues anticipated to be ahead of expectations for the year ending 30 September 2025

30 days ago

You can’t keep a high quality company down. Indeed despite the current R&D budget headwinds in the US (re NIH) which has already impacted several much bigger healthcare stocks (eg CROs), IXICO is bucking the trend.

Finseta reports 16% revenue growth in H1'25, confident in strong H2 performance

1 month ago

Finseta reported 16% revenue growth in H1 2025, with strong customer acquisition and new initiatives in Dubai and Canada positioning the company for accelerated performance in the second half.

Avingtrans reports strong FY25 performance, driven by Advanced Engineering growth

2 months ago

Avingtrans reports strong FY25 trading, with revenue and profits meeting upgraded forecast, driven by robust performance in Advanced Engineering Systems and strategic progress in Medical & Industrial Imaging.

IXICO assists FDA clearance of new Alzheimer’s blood-based diagnostic

2 months ago

IXICO’s AI platform supported Fujirebio in securing FDA clearance for a pioneering blood-based test that improves early Alzheimer’s diagnosis.

Eleco reports positive momentum and confidence in FY25 outlook

2 months ago

Eleco reports strong performance in early 2025, citing resilient product demand, a 39% share price increase since June 2024, and confidence in meeting full-year expectations.

Avingtrans reports strong FY25 performance, EBITDA to beat forecasts

3 months ago

Avingtrans expects FY25 adjusted EBITDA to surpass market forecasts, with revenues aligning to expectations, driven by strong results in the AES division.

Argentex shareholders face tough choice as IFX launches undervalued £3m takeover bid

3 months ago

Argentex’s major shareholders accepted a lowball £3m cash bid from IFX Payments amid a liquidity crisis, but minority investors may rally to reject the offer in hopes of a better deal or recovery.

Water Intelligence Q1 revenue climbs amid launch of Preventive Maintenance platform

3 months ago

Water Intelligence reports strong Q1 growth with an 8% YTD revenue increase, bolstered by the launch of its innovative Preventive Maintenance strategy to lead in proactive water management solutions.

IXICO posts 26% revenue growth and stronger margins in H1 2025, breakthroughs in neuroimaging analytics

3 months ago

IXICO announces 26% LFL sales growth, stronger margins and balance sheet, and key milestones in neuroimaging innovation in H1 2025, reinforcing its momentum in neurological drug development.

Venture Life Group shares soar on €62m disposal of CDMO assets

3 months ago

Venture Life Group divests its contract development and manufacturing operations (CDMO) and non-core products for €62m to Italy-based BioDue SpA, to streamline operations and accelerate growth in its core healthcare brands.

Eleco delivers record 2024 results: double-digit growth in revenue, profit, and dividends

4 months ago

Eleco posted stellar FY24 performance, surpassing market expectations with 16% revenue growth, 24% higher profitability, and record recurring revenue, driving strong cashflow and dividend increases.

Mpac Group reports FY24 results: record revenue, strong orderbook, positive FY25 outlook

4 months ago

Mpac Group delivers strong FY24 performance in line with expectations, with record revenue, enhanced margins, and a robust orderbook, positioning for continued growth in FY25

Finseta posts 26% revenue growth in FY24, expands product portfolio and global footprint

4 months ago

Finseta reported a 26% increase in revenue for FY24, driven by growth in active customers, new product launches eg the corporate card and mass payments, and expanded operations in Canada and the UAE.

Supreme delivers record £235m revenue in FY25, boosted by acquisitions

4 months ago

Supreme posts record FY25 revenue of £235m, fueled by strategic acquisitions, cost management, and solid growth in new and existing markets.

Belluscura reports strong Q1 growth, X-PLOR 5 launch, and CFO transition

4 months ago

Belluscura reports a significant increase in Q1 sales to $912k, launches the X-PLOR 5 portable oxygen concentrator, and announces the resignation of CFO Simon Neicheril, effective May 2, 2025.

IXICO delivers strong H1 2025 with 26% revenue growth and expanded US operations

4 months ago

IXICO reports a 26% revenue increase to £3.2m, a strengthened cash position, and strategic advancements in Alzheimer's and Parkinson's research during H1 2025.

Watchlist